Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Market Cap	7.22B
Revenue (ttm)	1.61B
Net Income (ttm)	500.28M
Shares Out	837.10M
EPS (ttm)	0.60
PE Ratio	14.42
Forward PE	12.87
Dividend	0.35 (4.06%)
Ex-Dividend Date	Jun 5, 2025

Volume	477,000
Average Volume	788,002
Open	8.61
Previous Close	8.62
Day's Range	8.51 - 8.63
52-Week Range	7.03 - 10.72
Beta	0.46
RSI	53.64
Earnings Date	Apr 29, 2025

About HKG:3613

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand name. Be...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1669
• Employees: 782
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3613

Financial Performance

In 2024, HKG:3613's revenue was 1.61 billion, an increase of 5.69% compared to the previous year's 1.52 billion. Earnings were 500.28 million, a decrease of -7.42%.